• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

中性粒细胞作为乳腺癌肿瘤微环境的关键调节因子:聚焦于N1和N2极化

Neutrophils as key regulators of tumor microenvironment in breast cancer: a focus on N1 and N2 polarization.

作者信息

Obeagu Emmanuel Ifeanyi, Ezeala Christian C

机构信息

Department of Biomedical Laboratory Science, Africa University, Mutare, Zimbabwe.

出版信息

Ann Med Surg (Lond). 2025 Apr 10;87(6):3509-3522. doi: 10.1097/MS9.0000000000003269. eCollection 2025 Jun.

DOI:10.1097/MS9.0000000000003269
PMID:40486595
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12140695/
Abstract

Neutrophils, the most abundant type of white blood cells in the human body, play a vital role in the immune response against infections and tissue injury. However, in the context of cancer, their function becomes more complex and context-dependent. In breast cancer, neutrophils are key players in shaping the tumor microenvironment (TME), a highly dynamic ecosystem where various cell types, extracellular matrix components, and soluble factors interact to influence tumor progression, immune evasion, and metastasis. Neutrophils in the TME are not just passive participants but actively engage in altering tumor biology, either supporting or inhibiting tumor growth depending on their polarization status. Neutrophils exhibit plasticity in their phenotype and function, which can be categorized into two polarized forms: N1 and N2. N1 neutrophils are associated with antitumor responses, promoting immune activation, direct cytotoxicity against tumor cells, and facilitating the clearance of cancerous cells through the release of reactive oxygen species, cytokines, and chemokines. Conversely, N2 neutrophils contribute to tumor progression by fostering an immunosuppressive environment, promoting angiogenesis, enhancing tumor cell migration and invasion, and aiding in the establishment of metastatic niches. This dichotomy of neutrophil polarization plays a crucial role in determining breast cancer progression, metastasis, and response to treatment.

摘要

中性粒细胞是人体中最丰富的白细胞类型,在抵抗感染和组织损伤的免疫反应中发挥着至关重要的作用。然而,在癌症背景下,它们的功能变得更加复杂且依赖于具体环境。在乳腺癌中,中性粒细胞是塑造肿瘤微环境(TME)的关键参与者,肿瘤微环境是一个高度动态的生态系统,其中各种细胞类型、细胞外基质成分和可溶性因子相互作用,影响肿瘤进展、免疫逃逸和转移。肿瘤微环境中的中性粒细胞不仅仅是被动参与者,而是根据其极化状态,积极参与改变肿瘤生物学特性,要么支持肿瘤生长,要么抑制肿瘤生长。中性粒细胞在其表型和功能上表现出可塑性,可分为两种极化形式:N1和N2。N1中性粒细胞与抗肿瘤反应相关,促进免疫激活、对肿瘤细胞的直接细胞毒性,并通过释放活性氧、细胞因子和趋化因子促进癌细胞的清除。相反,N2中性粒细胞通过营造免疫抑制环境、促进血管生成、增强肿瘤细胞迁移和侵袭以及协助建立转移龛来促进肿瘤进展。中性粒细胞极化的这种二分法在决定乳腺癌进展、转移和治疗反应方面起着关键作用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4052/12140695/adecaf6e83b8/ms9-87-3509-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4052/12140695/adecaf6e83b8/ms9-87-3509-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4052/12140695/adecaf6e83b8/ms9-87-3509-g001.jpg

相似文献

1
Neutrophils as key regulators of tumor microenvironment in breast cancer: a focus on N1 and N2 polarization.中性粒细胞作为乳腺癌肿瘤微环境的关键调节因子:聚焦于N1和N2极化
Ann Med Surg (Lond). 2025 Apr 10;87(6):3509-3522. doi: 10.1097/MS9.0000000000003269. eCollection 2025 Jun.
2
The balance between N1 and N2 neutrophils implications for breast cancer immunotherapy: a narrative review.N1和N2中性粒细胞之间的平衡对乳腺癌免疫治疗的影响:一项叙述性综述。
Ann Med Surg (Lond). 2025 May 12;87(6):3682-3690. doi: 10.1097/MS9.0000000000003361. eCollection 2025 Jun.
3
Prognostic significance and immune escape implication of tumor-infiltrating neutrophil plasticity in human head and neck squamous cell carcinoma.肿瘤浸润中性粒细胞可塑性在人头颈鳞状细胞癌中的预后意义及其免疫逃逸作用。
Hum Cell. 2024 May;37(3):714-728. doi: 10.1007/s13577-024-01024-7. Epub 2024 Feb 15.
4
Neutrophils and Neutrophil-Based Drug Delivery Systems in Anti-Cancer Therapy.中性粒细胞及基于中性粒细胞的抗癌治疗药物递送系统
Cancers (Basel). 2025 Apr 5;17(7):1232. doi: 10.3390/cancers17071232.
5
Neutrophils as active regulators of the immune system in the tumor microenvironment.中性粒细胞作为肿瘤微环境中免疫系统的活性调节因子。
J Leukoc Biol. 2017 Aug;102(2):343-349. doi: 10.1189/jlb.5MR1216-508R. Epub 2017 Mar 6.
6
Prognostic value of tumor-associated N1/N2 neutrophil plasticity in patients following radical resection of pancreas ductal adenocarcinoma.胰腺导管腺癌根治性切除术后肿瘤相关 N1/N2 中性粒细胞可塑性的预后价值。
J Immunother Cancer. 2022 Dec;10(12). doi: 10.1136/jitc-2022-005798.
7
Polymorphonuclear Neutrophils and Tumors: Friend or Foe?中性粒细胞与肿瘤:是敌是友?
Exp Suppl. 2022;113:141-167. doi: 10.1007/978-3-030-91311-3_5.
8
Smad3 is essential for polarization of tumor-associated neutrophils in non-small cell lung carcinoma.Smad3 对于非小细胞肺癌中肿瘤相关中性粒细胞的极化是必需的。
Nat Commun. 2023 Mar 31;14(1):1794. doi: 10.1038/s41467-023-37515-8.
9
Mechanistic insights into the interplays between neutrophils and other immune cells in cancer development and progression.深入了解中性粒细胞与其他免疫细胞在癌症发展和演进中的相互作用的机制。
Cancer Metastasis Rev. 2022 Jun;41(2):405-432. doi: 10.1007/s10555-022-10024-8. Epub 2022 Mar 21.
10
An Attempt to Polarize Human Neutrophils Toward N1 and N2 Phenotypes .尝试将人中性粒细胞向 N1 和 N2 表型极化。
Front Immunol. 2020 Apr 28;11:532. doi: 10.3389/fimmu.2020.00532. eCollection 2020.

引用本文的文献

1
N1 and N2 neutrophil subtypes in breast cancer: functional implications and clinical perspectives: a narrative review.乳腺癌中的N1和N2中性粒细胞亚型:功能影响及临床前景:一项叙述性综述
Ann Med Surg (Lond). 2025 Jul 18;87(9):5762-5769. doi: 10.1097/MS9.0000000000003609. eCollection 2025 Sep.
2
N2 Neutrophils and Tumor Progression in Breast Cancer: Molecular Pathways and Implications.N2中性粒细胞与乳腺癌的肿瘤进展:分子途径及影响
Breast Cancer (Dove Med Press). 2025 Jul 23;17:639-651. doi: 10.2147/BCTT.S542787. eCollection 2025.

本文引用的文献

1
Lymphocyte infiltration in breast cancer: A promising prognostic indicator.乳腺癌中的淋巴细胞浸润:一个有前景的预后指标。
Medicine (Baltimore). 2024 Dec 6;103(49):e40845. doi: 10.1097/MD.0000000000040845.
2
Tumor-associated macrophages in bladder cancer: roles and targeted therapeutic strategies.膀胱癌中的肿瘤相关巨噬细胞:作用和靶向治疗策略。
Front Immunol. 2024 Nov 13;15:1418131. doi: 10.3389/fimmu.2024.1418131. eCollection 2024.
3
Liquid biopsy for early cancer detection: technological revolutions and clinical dilemma.液体活检在早期癌症检测中的应用:技术革命与临床困境
Expert Rev Mol Diagn. 2024 Oct;24(10):937-955. doi: 10.1080/14737159.2024.2408744. Epub 2024 Oct 3.
4
Predictive models and biomarkers for survival in stage III breast cancer: a review of clinical applications and future directions.III期乳腺癌生存的预测模型和生物标志物:临床应用及未来方向综述
Ann Med Surg (Lond). 2024 Aug 30;86(10):5980-5987. doi: 10.1097/MS9.0000000000002517. eCollection 2024 Oct.
5
How neutrophils shape the immune response of triple-negative breast cancer: Novel therapeutic strategies targeting neutrophil extracellular traps.中性粒细胞如何塑造三阴性乳腺癌的免疫反应:靶向中性粒细胞胞外诱捕网的新治疗策略。
Biomed Pharmacother. 2024 Sep;178:117211. doi: 10.1016/j.biopha.2024.117211. Epub 2024 Jul 27.
6
Glucocorticoid receptors orchestrate a convergence of host and cellular stress signals in triple negative breast cancer.糖皮质激素受体在三阴性乳腺癌中协调宿主和细胞应激信号的汇聚。
J Steroid Biochem Mol Biol. 2024 Oct;243:106575. doi: 10.1016/j.jsbmb.2024.106575. Epub 2024 Jun 29.
7
Mechanisms underlying neutrophils adhesion to triple-negative breast cancer cells via CD11b-ICAM1 in promoting breast cancer progression.中性粒细胞通过 CD11b-ICAM1 黏附于三阴性乳腺癌细胞促进乳腺癌进展的机制。
Cell Commun Signal. 2024 Jun 21;22(1):340. doi: 10.1186/s12964-024-01716-5.
8
β-Lapachone promotes the recruitment and polarization of tumor-associated neutrophils (TANs) toward an antitumor (N1) phenotype in NQO1-positive cancers.β-拉帕醌促进 NQO1 阳性癌症中肿瘤相关中性粒细胞(TAN)向抗肿瘤(N1)表型的募集和极化。
Oncoimmunology. 2024 Jun 4;13(1):2363000. doi: 10.1080/2162402X.2024.2363000. eCollection 2024.
9
Breastfeeding's protective role in alleviating breast cancer burden: a comprehensive review.母乳喂养在减轻乳腺癌负担方面的保护作用:一项综述
Ann Med Surg (Lond). 2024 Mar 5;86(5):2805-2811. doi: 10.1097/MS9.0000000000001914. eCollection 2024 May.
10
Exploring the profound link: Breastfeeding's impact on alleviating the burden of breast cancer - A review.探讨深远关联:母乳喂养缓解乳腺癌负担的影响——综述。
Medicine (Baltimore). 2024 Apr 12;103(15):e37695. doi: 10.1097/MD.0000000000037695.